Cormorant Asset Management’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-2,870
| Closed | -$1.56M | – | 74 |
|
|
2017
Q1 | $1.56M | Hold |
2,870
| – | – | 0.23% | 65 |
|
|
2016
Q4 | $1.75M | Hold |
2,870
| – | – | 0.24% | 64 |
|
|
2016
Q3 | $2.05M | Hold |
2,870
| – | – | 0.23% | 65 |
|
|
2016
Q2 | $2.09M | Buy |
2,870
+34
| +1% | +$24.7K | 0.3% | 60 |
|
|
2016
Q1 | $1.69M | Hold |
2,836
| – | – | 0.25% | 64 |
|
|
2015
Q4 | $1.62M | Sell |
2,836
-1,754
| -38% | -$1M | 0.19% | 64 |
|
|
2015
Q3 | $2.57M | Hold |
4,590
| – | – | 0.41% | 54 |
|
|
2015
Q2 | $3.65M | Hold |
4,590
| – | – | 0.49% | 48 |
|
|
2015
Q1 | $3.82M | Sell |
4,590
-133
| -3% | -$111K | 0.59% | 46 |
|
|
2014
Q4 | $3.4M | Hold |
4,723
| – | – | 0.52% | 45 |
|
|
2014
Q3 | $3.28M | Hold |
4,723
| – | – | 0.67% | 40 |
|
|
2014
Q2 | $3.98M | Buy |
4,723
+29
| +0.6% | +$24.4K | 1.05% | 37 |
|
|
2014
Q1 | $7.67M | Buy |
+4,694
| New | +$7.67M | 1.76% | 25 |
|